SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001628280-23-000670 from Pear Therapeutics, Inc. (CIK 0001835567)

Pear Therapeutics, Inc. (CIK 0001835567)
Date: Jan. 6, 2023 · CIK: 0001835567 · Accession: 0001628280-23-000670

AI Filing Summary & Sentiment

File numbers found in text: 333-269097

Date
January 6, 2023
Author
Not clearly detected
Form
CORRESP
Company
Pear Therapeutics, Inc. (CIK 0001835567)

Letter

Document

Pear Therapeutics, Inc.

200 State Street, 13th Floor

Boston, MA 02109

January 6, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Pear Therapeutics, Inc.

Registration Statement on Form S-3

File No. 333-269097

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Pear Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269097) (the “Registration Statement”), so that it may become effective at 4:00 pm Eastern time on January 10, 2023, or as soon thereafter as practicable, or at such other time as the Registrant or its outside counsel, Foley Hoag LLP, requests by telephone that such Registration Statement be declared effective.

Please feel free to direct any questions or comments concerning this request to Stacie S. Aarestad, Esq. of Foley Hoag LLP at (617) 832-1108.

[Remainder of this page intentionally left blank]

Very truly yours,
PEAR THERAPEUTICS, INC.

Show Raw Text
CORRESP
1
filename1.htm

Document

Pear Therapeutics, Inc.

200 State Street, 13th Floor

Boston, MA 02109

January 6, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:         Pear Therapeutics, Inc.

Registration Statement on Form S-3

File No. 333-269097

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Pear Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269097) (the “Registration Statement”), so that it may become effective at 4:00 pm Eastern time on January 10, 2023, or as soon thereafter as practicable, or at such other time as the Registrant or its outside counsel, Foley Hoag LLP, requests by telephone that such Registration Statement be declared effective.

Please feel free to direct any questions or comments concerning this request to Stacie S. Aarestad, Esq. of Foley Hoag LLP at (617) 832-1108.

[Remainder of this page intentionally left blank]

Very truly yours,

PEAR THERAPEUTICS, INC.

By: /s/ Corey McCann

 Name: Corey McCann

Title: President and Chief Executive Officer

[Signature Page to Pear Therapeutics, Inc. Acceleration Request]